Kansas 2023-2024 Regular Session

Kansas House Bill HB2390

Introduced
2/9/23  
Refer
2/9/23  
Report Pass
2/17/23  
Engrossed
3/1/23  
Refer
3/2/23  

Caption

House Substitute for HB 2390 by Committee on Public Health and Welfare - Requiring the secretary of health and environment to study drug overdose death cases and providing for the confidentiality of acquired and related records, restricting the authority of the secretary of health and environment and local health officers to prevent the introduction and spread of infectious or contagious diseases and repealing the authority of the secretary to quarantine individuals and impose associated penalties.

Impact

The legislation mandates that the Secretary of Health and Environment oversee the board and study drug overdose cases, which includes reviewing autopsy reports and medical records—all while ensuring the confidentiality of such sensitive information. This confidentiality is crucial for encouraging open and honest discussions about overdose causes without fear of legal repercussions. Such measures are intended to facilitate better data collection and sharing among health care providers, law enforcement, and community services, ultimately aiming to enhance drug addiction treatment and prevention strategies in Kansas.

Summary

House Bill 2390 introduces the Kansas Overdose Fatality Review Board Act to address the alarming rise in drug overdose fatalities in Kansas. The act aims to establish a systematic approach to review overdose death cases by forming a specialized board which will analyze relevant data, identify patterns, and recommend evidence-based strategies to prevent such tragedies in the future. The board's composition will include various stakeholders from health, law enforcement, and social services to ensure a comprehensive understanding of the issues surrounding drug fatalities.

Contention

Despite its benefits, the bill has raised some concerns regarding the implications of extensive data collection and the confidentiality provisions. Critics argue that while protecting individual identities is vital, the bill also creates a potential barrier to accessing necessary information that could inform public health interventions and policy changes. Moreover, ensuring that numerous government agencies cooperate effectively within the confines of confidentiality may pose a practical challenge to the success of the review board's objectives.

Companion Bills

No companion bills found.

Similar Bills

KS SB287

House Substitute for SB 287 by Committee on Health and Human Services - Prohibiting a healthcare provider from administering medication, diagnostic tests or conducting ongoing behavioral health treatments to a minor in a school facility without parental consent, enacting the no patient left alone act to require medical care facilities to allow in-person visitation in certain circumstances, expanding licensure of rural emergency hospitals that meet criteria between January 2015 and December 2020 and authorizing emergency medical responders to distribute non prescription over-the-counter medications.

RI H7131

Opioid Alternatives

RI S2611

Opioid Alternatives

CT SB01355

An Act Concerning Prescription Drugs, Devices And Nonlegend Drugs.

RI H5615

Revises sections of the uniform controlled substances act to remove specific opioid dosage requirements, revises the uniform controlled substances act in accordance with current standards of professional practice and would repeal chapter 37.4 of title 5.

IL HB5530

PHARMACY PRACTICE-INJECTIONS

MS SB2336

Prevention of overdoses; authorize administration of opioid antagonists by certain persons, provide immunity to.

MA H4758

Relative to treatments and coverage for substance use disorder and recovery coach licensure